OR-POWIN
7.5.2024 15:01:37 CEST | Business Wire | Press release
Global energy storage platform provider Powin LLC (Powin) today announced its new multi-cell-based hardware platform, the Powin Pod (Pod). Designed for utility-scale projects, Pod takes Powin’s battery energy storage system (BESS) technology to the next level, setting a new standard for energy storage solutions with higher energy density, top-tier safety, reliability and enhanced cost savings. The Pod platform complements Powin's Centipede product line, offering a comprehensive suite of solutions to meet diverse customer requirements.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240507995695/en/
Powin's new multi-cell-based hardware platform, the Powin Pod. (Photo: Business Wire)
"We consistently challenge ourselves to improve our products and services to ensure we are continuously delivering nothing short of excellence to both new and existing customers," said Jeff Waters, CEO of Powin. "This next-generation product advancement demonstrates our commitment to bringing the safest and highest quality energy storage solutions to the market, advancing the entire industry as a result."
The new Pod platform is part of a fully integrated Powin energy storage solution that includes an end-to-end offering—spanning StackOS software, system design, delivery, commissioning and long-term service—that will enable Powin to meet growing customer needs with an improved, reliable and energy-dense storage platform. Powin’s proprietary Battery Management System and Energy Management controls comply with robust localized cybersecurity standards and regulations, ensuring superior protection for data privacy and intellectual property, guaranteeing security of customers’ data, operations and investment at all times. Customers who select Pod will benefit from Powin's full authorization to perform long-term services at their site, as well as comprehensive system training from the company. Within a fully integrated solution, Powin delivers safety, availability, insight and flexibility, providing lower risk, enhanced performance and improved revenue generation.
The Powin Pod platform offers benefits such as:
- Higher-density energy storage: Upgraded cell capacity, utilization of cell-to-pack technology and optimized internal space maximizes energy density and results in significant land savings for projects. Powin Pod delivers a 50% increase in energy density from the Powin Centipede platform. This solution and density improvement is available at 2-hour or greater system applications.
- Top-tier safety and reliability: Liquid cooling provides more stable internal battery system temperatures, ensuring enhanced system safety and longevity. Powin complies with the latest and most stringent fire prevention standards such as UL9540A, NFPA 68 and NFPA 69, while having optional class-leading fire suppression at module and container level.
- Enhanced cost savings: Powin Pod’s compact size reduces the amount of land required for installation, and Powin’s faster and lower cost shipping and on-time delivery combined with simplified installation and commissioning processes allow for lower CAPEX and greater customer savings.
With a proven track record of over 17 GWh deployed and under construction worldwide and over six million battery cells monitored, Powin is a trusted and established US-based integrator. Powin provides world-class logistics for on-time delivery, 20-year performance guarantee and long-term service structures and relies on a 24/7 Remote Operations Center and over 500 field service technicians and Authorized Service Providers to ensure optimal system performance.
Powin Pod is now available to order in markets globally and delivery is expected to begin in mid-2025. Starting in 2026, Powin Pod will be manufactured in the US complying with US Domestic Content requirements. To learn more about Powin’s latest product advancements, please visit https://powin.com/powin-pod/ or visit the Powin team at CLEANPOWER 2024 at booth #2645.
About Powin, LLC (Powin)
At Powin, we are advancing the next frontier of energy and changing the way we power our daily lives by ensuring access to clean, resilient, and affordable power. As a global energy storage platform provider, we offer fully integrated battery solutions, software, and services to optimize grid performance and enable the transition to cleaner energy sources. To learn more, please visit www.powin.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240507995695/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Inspirit Capital to Acquire Kaplan Languages Group20.4.2026 17:15:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, is pleased to announce its plans to acquire KLG Kaplan Languages Group (“KLG”), a leading global language education platform, from Kaplan. All conditions for the sale have been met, and completion is due to take place on 1 May. KLG comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Since 2006, KLG has provided high-quality language education, supporting students in achieving their language goals through academic excellence, cultural immersion, and life-changing experiences. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. This next phase of ownership will also see the development of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. Paul Youens, Investment Director, Inspirit Capital: “KLG has built a st
Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys20.4.2026 16:00:00 CEST | Press release
Industry’s most widely adopted PETG material meets industry-leading cleanliness, compliance, and RNase/DNase-free validation—now available across the full bioprocessing workflow. SaniSure® today announced the launch of PETG PharmaTainer™, a new line of bioprocessing bottles and carboys combining widely accepted, medical-grade Eastman Eastar® PETG 6763 resin (DMF#9987) with SaniSure’s proprietary process and advanced automation. This launch expands SaniSure’s established PharmaTainer® platform—extending its proven cleanliness, robustness, and performance attributes to include industry-standard PETG alongside its existing PET and PC offerings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420641769/en/ PETG PharmaTainer™ bottles and carboys—RNase/DNase-free, ultra-clean, ready-to-use containers for bioprocessing applications. Available in volumes from 10 mL stability vials to 10 L carboys — in sterile (gamma-irradiated) an
Leaders of Dubai-Based Unicorns Hail City as Global Innovation Hub Shaping Future Technology and Driving the Digital Economy20.4.2026 15:08:00 CEST | Press release
Leaders of Dubai-based unicorn companies have reaffirmed the emirate’s status as a global hub for digital innovation and technology-led growth. The senior executives highlighted Dubai’s forward-looking regulatory environment, advanced infrastructure, and ability to attract international talent as key factors strengthening its appeal for high-growth digital businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420503062/en/ Leaders of Dubai-based unicorns hail city as global innovation hub shaping future technology and driving the digital economy (Photo: AETOSWire) They noted that Dubai has evolved into a strategic launchpad for ambitious companies, offering an agile business environment that supports innovation and enables expansion into regional and international markets. The business leaders also praised the strong alignment between the public and private sectors within Dubai’s digital ecosystem, supported by Dubai
Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 15:00:00 CEST | Press release
– Highly innovative and original gameplay earns strong reception from players around the globe – Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broade
Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 14:30:00 CEST | Press release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
